Latest Production News

BCI Minerals edges closer to first salt shipment at its Mardie Project, with crystallisation underway and 85% construction complete. The company maintains full funding and advances its sulphate of potash opportunity alongside robust sustainability initiatives.

Fletcher Building (ASX:FBU) reversed its FY25 loss with a $228 million net profit in FY26, driven by a 26% rise in EBIT and a $362 million reduction in net debt amid portfolio simplification and operational improvements.

Turners Automotive Group delivered record FY26 results with a 14% dividend rise, underpinned by strong growth in Auto Retail, Finance, and Insurance despite geopolitical headwinds.

Taiko Critical Minerals has successfully closed a NZ$2.5 million Share Purchase Plan, issuing over 10 million shares at NZ$0.25 each to support the development of its Barrytown Critical Minerals Project.

EBOS Group posted a solid FY26, growing revenue nearly 10% to $13.5 billion and underlying EBITDA 5% to $614 million, while completing a major distribution centre renewal program. The company maintains its final dividend and sets a confident growth outlook for FY27.

Brisbane Broncos expect a 33% increase in half-year net profit before tax to $11.57 million, driven by higher crowd attendance and merchandise sales despite reduced ARLC funding and rising costs.

BCI Minerals has contracted Bluestar Lehigh to build a 150 kg/hr sulphate of potash pilot plant at Mardie, aiming to de-risk commercial SOP production. Commissioning is set for early FY2028 with piloting to span about a year, funded within the existing $1.443 billion Mardie budget.

AXP Energy is installing a 320kW natural gas generator at its Edwards Lease in Oklahoma to power digital mining equipment, marking its first commercial gas-to-power project following a successful Colorado trial.

JPMorgan Asset Management confirms final cash distributions and reinvestment prices for six Equity Premium Income ETFs for August 2026, following recent structural changes in four funds.

Ignite Limited reported an 18.8% drop in revenue to $73.2 million and a 29.4% fall in statutory profit to $0.87 million for FY2026, while maintaining a 13% gross margin and declaring a fully franked final dividend.

Xenitra’s Hong Kong subsidiary Fukang has inked a three-year A$5 million procurement framework for specialised medical nutrition products, broadening its foothold beyond OTC medicines in China’s booming healthcare market.

Brazilian Rare Earths (ASX: BRE) has unveiled a scoping study for its Monte Alto and Camaçari project in Bahia, Brazil, showcasing ultra-high grades and robust economics with a post-tax NPV8 of US$6 billion and a rapid 1.1-year payback.